Yang W T, Lam W W, Cheung H, Suen M, King W W, Metreweli C
Department of Diagnostic Radiology and Organ Imaging, Chinese University of Hong Kong, Shatin, Hong Kong.
J Ultrasound Med. 1997 Dec;16(12):791-7. doi: 10.7863/jum.1997.16.12.791.
High resolution sonographic (39 cases), magnetic resonance imaging (32 cases), and mammographic (35 cases) measurements of preoperative size of breast cancer were correlated with the pathologic size in 39 patients with breast carcinoma to determine the most accurate imaging technique for breast cancer size. There were nine T1, 21 T2, four T3, and four T4 tumors. Sonographic and magnetic resonance imaging measurements of tumor size demonstrated correlation coefficients of 0.92 and 0.93, respectively, both of which were superior to that of mammography (0.84). Sonographic tumor size evaluation thus is shown to be equivalent to magnetic resonance imaging in this study. Three of nine (33%), four of seven (57%), and four of eight (50%) T1 tumors would have been overstaged by ultrasonography, magnetic resonance imaging, and mammography, respectively. Three of 21 (14.3%), one of 16 (6.3%), and two of 18 (11.1%) T2 tumors would have been understaged by ultrasonography, magnetic resonance imaging, and mammography, respectively. We therefore found ultrasonography to be of value in the diagnosis and staging of breast cancer.
对39例乳腺癌患者进行了高分辨率超声检查(39例)、磁共振成像(32例)和乳腺钼靶检查(35例),以测量术前乳腺癌大小,并将其与病理大小进行关联,从而确定最准确的乳腺癌大小成像技术。其中有9例T1肿瘤、21例T2肿瘤、4例T3肿瘤和4例T4肿瘤。肿瘤大小的超声测量和磁共振成像测量的相关系数分别为0.92和0.93,两者均优于乳腺钼靶检查(0.84)。因此,在本研究中,超声对肿瘤大小的评估与磁共振成像相当。9例T1肿瘤中,分别有3例(33%)、4例(57%)和4例(50%)会因超声检查、磁共振成像和乳腺钼靶检查而被高估分期。21例T2肿瘤中,分别有3例(14.3%)、1例(6.3%)和2例(11.1%)会因超声检查、磁共振成像和乳腺钼靶检查而被低估分期。因此,我们发现超声检查在乳腺癌的诊断和分期中具有价值。